Pharming Group N.V. (PHAR) Financials

PHAR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 468.0 million 197.5 million
March 31, 2026 489.4 million 220.4 million
Dec. 31, 2025 499.8 million 222.8 million
Sept. 30, 2025 403.6 million 178.1 million

PHAR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.8 million 3.4 million
March 31, 2026 1.7 million 3.2 million
Dec. 31, 2025 10.4 million 4.5 million
Sept. 30, 2025 32.0 million 3.2 million

PHAR Net Income

No data available :(

PHAR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 158.3 million 92.4 million 15.4 million
March 31, 2026 170.9 million 93.4 million 14.7 million
Dec. 31, 2025 179.8 million 92.7 million 17.7 million
Sept. 30, 2025 141.5 million 79.3 million 27.7 million

PHAR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 70.1 million
March 31, 2026 70.1 million
Dec. 31, 2025 75.8 million
Sept. 30, 2025 66.9 million

PHAR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 82447 32.3 million 43.5 million 28.6 million
March 31, 2026 238000 25.6 million 45.5 million 30.3 million
Dec. 31, 2025 269000 32.1 million 51.3 million 31.3 million
Sept. 30, 2025 70000 23.4 million 51.1 million 34.1 million

PHAR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 90.2 million 14.5 million
March 31, 2026 72.4 million 6.6 million
Dec. 31, 2025 106.5 million 21.1 million
Sept. 30, 2025 97.3 million 7.1 million

PHAR

Price: $11.23

52 week price:
9.62
21.34

Earnings Per Share: 0.15 USD

P/E Ratio: 68.40

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 1500

Market Capitalization: 767.9 million

Links: